Evidence map›Paper›PMID 29316677›Full record

ArticleMolecules (Basel, Switzerland)2018

Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.

Gülhan Turan-Zitouni, Weiam Hussein, Begüm Nurpelin Sağlık, Aouatef Tabbi, Büşra Korkut

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. (Molecules (Basel, Switzerland) · 2023
    Article
  4. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Gülhan Turan-ZitouniDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. gturan@anadolu.edu.tr.
Weiam HusseinDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. white.wf.rose@gmail.com.
Begüm Nurpelin SağlıkDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. bnsaglik@anadolu.edu.tr.
Aouatef TabbiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. awateftabbi@yahoo.fr.
Büşra KorkutDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. busrakorkut@anadolu.edu.tr.
Eskişehir City Hospital · TRAnadolu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new series of

Indexed as

AnimalsCatalytic DomainHydrazonesInhibitory Concentration 50KineticsMiceMolecular Docking SimulationMonoamine OxidaseMonoamine Oxidase InhibitorsNIH 3T3 CellsPyridinesStructure-Activity RelationshipHydrazonesMonoamine OxidaseMonoamine Oxidase InhibitorsPyridinesenzyme kinetic studiesinhibitory potencyMAO inhibitorsN-pyridyl-hydrazone derivatives

Identifiers

PMID29316677
PMCPMC6017090
OpenAlexW2782575318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.